Evaluating laser acupuncture for shoulder pain after stroke

To Evaluate the Therapeutic Effect of Laser Acupuncture in Patients With Acute or Subacute Post Stroke Shoulder Pain

Not applicable Interventional Chang Gung Memorial Hospital · NCT05328401

This study is testing if laser acupuncture can help people with shoulder pain after a stroke feel better and improve their shoulder movement.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment58 (estimated)
Ages20 Years and up
SexAll
SponsorChang Gung Memorial Hospital Academic / other
Locations1 site (Keelung, Taiwan)
Trial IDNCT05328401 on ClinicalTrials.gov

What this trial studies

This study aims to assess the effectiveness of laser acupuncture in alleviating shoulder pain and enhancing shoulder function recovery in patients who have experienced a stroke. It focuses on individuals suffering from post-stroke shoulder pain, a common complication that can significantly impact recovery. Participants will be divided into groups receiving either verum (active) laser acupuncture or sham (placebo) laser acupuncture to determine the therapeutic effects. The study will include patients in the subacute and chronic phases of recovery, ensuring they meet specific eligibility criteria.

Who should consider this trial

Good fit: Ideal candidates are adults over 20 years old who are in the subacute or chronic phase of post-stroke recovery and experiencing shoulder pain.

Not a fit: Patients with pre-existing shoulder pain before their stroke or those with acute shoulder trauma or surgery on the affected side will not benefit from this study.

Why it matters

Potential benefit: If successful, this treatment could provide a non-invasive option for managing shoulder pain in stroke survivors, potentially improving their quality of life and recovery outcomes.

How similar studies have performed: While the specific application of laser acupuncture for post-stroke shoulder pain is novel, similar approaches using acupuncture for pain management have shown promise in other studies.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Beyond the age of 20.
* Normal consciousness before and after stroke who can reply and fill in the questionnaire.
* Subacute (subacute phase: 7 days to 6 months after stroke) and Chronic (chronic phase: more than 6 months after stroke) with shoulder pain after stroke and in post- stroke recovery period.
* Stop taking painkillers for more than 1 day,
* Without received intramuscular drugs (steroids, botulinum toxin, glucose, etc.) injections in the shoulder joint or around the shoulder for more than 2 weeks
* Those willing to sign the written subject consent form.

Exclusion Criteria:

* Participants with shoulder pain symptoms before the stroke
* Acute shoulder trauma on the affected side of shoulder pain in the past.
* Surgery on the affected side of shoulder pain in the past.
* Those who cannot complete the scale assessment due to aphasia, post-stroke depression, and obvious cognitive impairment.
* Women who are pregnant or planning to become pregnant.
* Those who have a history of epilepsy and are receiving anti-epileptic drug treatment.
* Who are receiving any herbal or folk remedies related to shoulder pain.
* Any other conditions deemed unsuitable in the assessment of the responsible physician.
* Those who have not signed the written subject consent form.

Where this trial is running

Keelung, Taiwan

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Post Stroke Shoulder Pain
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.